Fulgent Genetics (FLGT) CFO has 2,747 shares withheld for RSU taxes
Fulgent Genetics' CFO and Treasurer, Paul Kim, had 2,747 shares of common stock withheld on April 26, 2026, to cover tax obligations arising from the vesting of restricted stock units. This was a routine tax-related disposition, not an open-market sale, and the shares were valued at $16.31 each. Following this transaction, Kim continues to hold a substantial 365,800 shares of Fulgent common stock.
How this was made
The 30-second read
Why it matters
This transaction is routine and does not reflect new information about the company's financial health or prospects.
Market read
The event has minimal impact on the company's stock and is unlikely to influence market perception.
What to watch
This activity is routine and does not indicate insider trading or material information; overinterpreting could lead to unnecessary trading.
Background
The CFO of Fulgent Genetics withheld shares to cover tax obligations from vested RSUs, a common practice among executives.
Ticker impact
The insider transaction involves the CFO of Fulgent Genetics, indicating potential insider confidence or tax planning activities.
Minimal to no impact on stock price; likely negligible movement.
Such tax-related withholding is common and does not reflect a change in company fundamentals or insider sentiment.
Market effects
Limited; this insider activity is specific to company tax obligations and does not indicate sector-wide changes.
None; event is company-specific and internal.
Negligible; no broader market implications.
Counterpoint
Some traders might interpret insider withholding as a sign of confidence in future stock performance, potentially leading to a slight positive bias.
Key entities
- CompanyFulgent Genetics
A biotechnology company specializing in genetic testing.
- ExecutivePaul Kim
CFO and Treasurer of Fulgent Genetics.
